| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/20/2002 | US6437112 Dna encodes polypeptide of fusion protein or tail fiber proteins of bacteriophage t4 |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437110 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/20/2002 | US6437109 System for in vitro transposition |
| 08/20/2002 | US6437108 Essential bacterial genes and their use |
| 08/20/2002 | US6437100 DNA encoding a human histamine receptor of the H3 subtype |
| 08/20/2002 | US6437098 Genetic engineering; anticarcinogenic agents; side effect reduction |
| 08/20/2002 | US6437097 Mammalian pro-apoptotic Bok genes and their uses |
| 08/20/2002 | US6437096 Diagnosing infections; vaccines; genetic engineering and expression |
| 08/20/2002 | US6437095 Method for producing chimeric polypeptides |
| 08/20/2002 | US6436909 Antisense inhibition of transforming growth factor-β expression |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436888 α-amylase mutants |
| 08/20/2002 | US6436709 Low pressure-accelerated particle gene gun |
| 08/20/2002 | US6436708 Delivery system for gene therapy to the brain |
| 08/20/2002 | US6436707 Trap cassette and splice acceptor; polyadenylation sequence defining 3' end of first exon; high speed screening; gene expression |
| 08/20/2002 | US6436706 Antisense inhibitor of RECQL4 expression |
| 08/20/2002 | US6436703 Polynucleotide; genetic engineering and gene expression; cloning, molecular hybridization; medical diagnosis |
| 08/20/2002 | US6436700 Anti-sense p21 k-ras |
| 08/20/2002 | US6436694 Regulable gene expression in gram-positive bacteria |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436691 Chemical compounds |
| 08/20/2002 | US6436690 Isolated bpn' variant having modified amino acid sequence of subtilisin bpn' wild-type amino acid sequence comprising substitution at one or more positions in one of loop regions; cleaning compositions |
| 08/20/2002 | US6436688 Isolated dna molecule having nucleotide sequence encoding polypeptide having specified amino acid sequence |
| 08/20/2002 | US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436683 Isolated polypeptide comprising selected amino acid sequence having nucleic acid methylase activity |
| 08/20/2002 | US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences |
| 08/20/2002 | US6436681 Method for producing biotin |
| 08/20/2002 | US6436677 Combining thermoactinomyces vulgaris dna polymerase, sample containing rna, primer, buffer comprising magnesium ions and substantially free of manganese ions; reacting mixture such that polymerase reverse transcribes rna to cdna |
| 08/20/2002 | US6436676 Contacting nucleic acid having 5' cap structure with fusion protein comprising eif-4e domain and eif-4g domain joined by linker domain under conditions sufficient to form complex, isolating complex |
| 08/20/2002 | US6436675 Synthesizing, hybridizing, and elongating set of overlapping codon-varied oligonucleotides to provide population of recombined nucleic acids |
| 08/20/2002 | US6436674 Recombinant dna containing dna encoding secretion signal which is more than 60% homologous to amino acid sequence of e. coli oppa secretion signal operatively linked to dna encoding human growth hormone having molecular weight of about 20,000 |
| 08/20/2002 | US6436673 Isolated polynucleotide encoding neuronal-activity regulated pentraxin, narp, polypeptide having specified amino acid sequence |
| 08/20/2002 | US6436672 Polynucleotides encoding a type V adenylyl cyclase |
| 08/20/2002 | US6436671 Isolated nucleic acid comprising nucleotide sequence that encodes human pi3k-c2-alpha, a phosphoinositide lipid kinase, having specified amino acid sequence |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436669 Isolated nucleic acid molecule comprising polynucleotide having specified nucleotide sequence or sequence encoding specified amino acid sequence |
| 08/20/2002 | US6436668 Process for the expression and production of the recombinant growth factor protein (BEGF) derived from BEAN 58058 virus (BEV) |
| 08/20/2002 | US6436664 Method for producing shikimic acid |
| 08/20/2002 | US6436657 Polynucleotides encoding aminomethyltransferases |
| 08/20/2002 | US6436656 Method for screening a test compound for potential as an immunosuppressive drug candidate |
| 08/20/2002 | US6436646 Contacting target nucleic acid sequence with complementary labeled probe; molecular hybridization increases level of polycation |
| 08/20/2002 | US6436645 Method for predicting risk of developing chronic pulmonary emphysema |
| 08/20/2002 | US6436644 Enzymatic nucleic acid cleaves rna; inflammation and autoimmune disease treatment; medical diagnosis |
| 08/20/2002 | US6436643 Transforming mold cell containing restriction site for rare-cutting endonuclease in its chromosomal dna |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/20/2002 | US6436637 Polynucleotide; expression vector; antiinflammatory agents; cell proliferative and apoptosis disorder treatment |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436409 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | US6436402 Process for making human papillomavirus virus-like particles with improved properties |
| 08/20/2002 | US6436400 Protease-activated receptor PAR4 ZCHEMR2 |
| 08/20/2002 | US6436396 Polypeptides having L-asparaginase activity |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436392 Dna segment confers increased episomal stability, persistence or abundance of the isolated dna molecule in a host cell |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6436387 Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 08/20/2002 | CA2340475C Orphan receptor |
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2228394C Novel catalase, the gene thereof and composition comprising the same, and process for preparing catalase using genetic engineering technology |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2165678C Plants having modified response to ethylene |
| 08/20/2002 | CA2145664C Oligonucleotides having a conserved g4 core sequence |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/20/2002 | CA1341385C Mutation of human granulocyte colony stimulating factor to allow the addition of carbohydrate chains at novel positions |
| 08/20/2002 | CA1341384C Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav |
| 08/15/2002 | WO2002063299A1 Low affinity screening method |
| 08/15/2002 | WO2002063298A2 Gap junction permeability assay |
| 08/15/2002 | WO2002063293A1 Production of a monoclonal antibody by a transgenic avian |
| 08/15/2002 | WO2002063280A1 Ligand sensor devices and uses thereof |
| 08/15/2002 | WO2002063043A1 Multitemperature single strand conformation polymorphism (msscp) |
| 08/15/2002 | WO2002063042A1 Apparatus for isolating nucleic acid or biological material |
| 08/15/2002 | WO2002063039A2 Gene silencing gene |
| 08/15/2002 | WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | WO2002063037A2 Method for identifying functional nucleic acids |
| 08/15/2002 | WO2002063036A2 Vector system used in screening active substances |
| 08/15/2002 | WO2002063032A1 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 08/15/2002 | WO2002063030A2 Charge tags and separation of nucleic acid molecules |
| 08/15/2002 | WO2002063029A1 Alteration of phenotype due to heterologous genes |
| 08/15/2002 | WO2002063026A1 Complexes and components thereof for introducing polynucleotides into eukaryotic cells |
| 08/15/2002 | WO2002063025A2 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 08/15/2002 | WO2002063024A2 Sustained totipotent culture of selected monocot genera |
| 08/15/2002 | WO2002063023A2 Sustained totipotent regenerable tissue culture of arundo donax (giant reed) and totipotent tissue and plants produced therefrom |
| 08/15/2002 | WO2002063022A2 Plant regulatory sequences |
| 08/15/2002 | WO2002063021A2 Nucleotide sequence mediating male fertility and method of using same |
| 08/15/2002 | WO2002063020A2 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields |
| 08/15/2002 | WO2002063019A2 Methods for generating resistance against cgmmv in plants |
| 08/15/2002 | WO2002063018A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | WO2002063016A1 Tocopherol cyclase |
| 08/15/2002 | WO2002063015A1 Aspartyl protease |
| 08/15/2002 | WO2002063014A2 Human tyrosine-specific protein phosphatase |
| 08/15/2002 | WO2002063013A2 Human acid phosphatase gene |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063011A1 Plant-derived molecules and genetic sequences encoding same and uses therefor |